• Company
• Qalsody receives orphan drug designation in Korea
• by Eo, Yun-Ho Aug 8, 2024 09:24am

• Company
• Vaxneuvance increases presence in NIP mkt
• by Hwang, Byung-woo Aug 8, 2024 09:24am

• Company
• Electronic drugs show potential to conquering Alzheimer's
• by Son, Hyung-Min Aug 8, 2024 09:24am

• Company
• Tepezza receives orphan drug designation in Korea
• by Eo, Yun-Ho Aug 6, 2024 09:16am

• Company
• Lily Korea appoints John Bickel as new General Manager
• by Hwang, Byung-woo Aug 6, 2024 09:16am

• Company
• Trials start for 'cancer vaccine+immunooncology drug’ combo
• by Son, Hyung-Min Aug 6, 2024 09:16am

• Company
• Entresto sales soar… rises 22% in 1 year
• by Kim, Jin-Gu Aug 6, 2024 09:15am

• Company
• Nabota records KRW 92B in North American sales in Q2
• by Son, Hyung-Min Aug 5, 2024 07:51am

• Company
• Pemazyre may be prescribed at general hospitals in Korea
• by Eo, Yun-Ho Aug 5, 2024 07:51am

• Company
• Obesity drugs, 'Wegovy vs Mounjaro' after expanded approval
• by Hwang, Byung-woo Aug 5, 2024 07:51am